genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2018

Diclofenac

Prescription Painkiller Boosts Risk of Heart Attack, Stroke
News

Prescription Painkiller Boosts Risk of Heart Attack, Stroke

GEN Staff Writer -
September 5, 2018
0
Impax Buys Generic Product Portfolio from Teva, Allergan for $586M
Industry News

Impax Buys Generic Product Portfolio from Teva, Allergan for $586M

GEN Staff Writer -
June 21, 2016
0
Depomed Buys U.S. Rights to Nucynta Franchise for $1.05B
Drug Discovery

Depomed Buys U.S. Rights to Nucynta Franchise for $1.05B

GEN Staff Writer -
January 16, 2015
0
BioLineRx Gains Rights to Antipain Candidate from Tel Aviv University
Drug Discovery

BioLineRx Gains Rights to Antipain Candidate from Tel Aviv University

GEN Staff Writer -
September 7, 2011
0
Javelin Pharmaceuticals Signs Supply Pact with Baxter Healthcare
News

Javelin Pharmaceuticals Signs Supply Pact with Baxter Healthcare

GEN Staff Writer -
May 22, 2007
0

Read the Digital Edition

August 2023 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up